Navigation Links
The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments
Date:4/30/2008

A Significant Accomplishment for the PLSG and the Life Sciences Industry in

Western Pennsylvania

PITTSBURGH, April 30 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, announced that the PLSG has reached a significant milestone with over $10 million in direct company investments. PLSG's investment of $235,000 in Lipella Pharmaceuticals for the support of pre-clinical testing and manufacturing of their therapy for the treatment of bladder dysfunction pushed them over the $10 million mark.

Since forming in 2002, the PLSG has committed $10.1 million into its Investment Portfolio of 48 life sciences companies which has leveraged over $300 million in additional capital for these emerging businesses. The PLSG continues to propel the growth of western Pennsylvania's life sciences economy by investing in the commercialization of promising life sciences technologies.

"Hitting the $10 million mark is a significant accomplishment for the PLSG and the life sciences industry in our region," said John W. Manzetti, PLSG president & CEO. "We are making a significant impact on life sciences commercialization in western Pennsylvania: new company formation is up, new wealth is being created, and new products -- with important, positive ramifications for human health and quality of life -- are beginning to reach the marketplace."

As western Pennsylvania's only organization solely focused on the biosciences industry, the PLSG has brought the required energy, domain-specific expertise and efficiency to the task of establishing a critical mass of life sciences awareness, research, development and commercialization in the region. The task moving forward is to expand those efforts and increase the successful commercialization of viable life sciences ventures.

Mr. Manzetti continued, "in addition to our direct investments into companies, we are working with over 250 companies to guide them through the difficult challenges they face in the early stages of company development. We also fuel the expansion of life sciences companies in the growth and maturity stages by supporting new product and market developments and through our Venture Capital Partnerships program to guide investment firms or individual investors to emerging life sciences opportunities in western Pennsylvania."

Mr. Manzetti concluded, "the PLSG team is committed to serving our clients by providing executive talent, business and domain experience and capital to bring our region's concepts to the market. Our combined domain and business experience is unmatched, and we are bringing more technologies into our "Concept to Commercialization(TM)" pipeline each and every day. Our work is attracting talent, technology and capital to the region to make the mission a success."

Summary of PLSG Accomplishments to Date:

-- The PLSG has invested $10.1 million directly into 48 companies to help

leverage over $300 million in additional capital.

-- The PLSG has assisted over 250 clients/companies through its Executive-

in-Residence program.

-- The PLSG has invested $15.2 million in venture capital funds to help

leverage an additional $110 million in total funding.

-- The PLSG's SBIR Advance program has assisted nearly 100 companies with

their federal grant strategies. To date, these companies have received

over $13 million in federal grant funding.

-- The PLSG has provided 27 early stage companies and venture capital and

life sciences organizations with office and laboratory space in our

incubator.

-- The PLSG has assisted 10 life sciences companies with relocating to our

region and is working with other companies who would like to establish

operations in southwestern Pennsylvania.

-- The PLSG has leveraged $2.4 million in federal grant money to help

provide core and customized life sciences specific workforce training

to over 5,000 trainees since September, 2005.

-- The PLSG has helped create 5,000 jobs directly/indirectly including

university faculty and facilities. (300+ jobs created in invested

companies and 1,000+ jobs in PLSG active companies/clients)

-- 25 executives have participated in the PLSG EIR program: 7 are

currently active at PLSG and 16 former EIRs remain in the region.

-- The regional life sciences company formation rate has increased from 2-

3 per year to 15-20 new companies per year.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in western Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the region. http://www.plsg.com


'/>"/>
SOURCE The Pittsburgh Life Sciences Greenhouse
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
2. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio
5. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
6. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
7. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
8. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
9. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
10. Caliper Life Sciences Reports West Coast Consolidation of Operations
11. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... their findings on what they believe could be a new and helpful biomarker ... new research. Click here to read it now. , Biomarkers are ...
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a range ... place between the two entities said Poloz. Speaking ... Ottawa , he pointed to the country,s inflation ... federal government. "In ... "Both institutions have common economic goals, why not sit down ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):